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29.1  IntroductIon
29.1.1  ClassifiCation, Morphology, and Biology
The genus Emmonsia (obsolete synonym: Haplosporangium) 
belongs to the mitosporic Onygenales group, order Onygenales, 
class Eurotiomycetes, subphylum Pezizomycotina, phylum 
Ascomycota, kingdom Fungi. The mitosporic Onygenales 
group consists of nine genera: Blastomyces, Chrysosporium, 
Coccidioides, Emmonsia, Geomyces, Locazia, Malbranchea, 
Myriodontium, and Paracoccidioides. Currently, the 
genus Emmonsia is divided into three recognized spe-
cies, Emmonsia crescens (synonyms: Emmonsia parva 
var. crescens and Chrysosporium parvum var. crescens), 
Emmonsia parva (synonyms: Emmonsia parva var. parva, 
Chrysosporium parvum, and Haplosporangium parvum), 
and Emmonsia pasteuriana, and nine unassigned species [1]. 
The type species of the genus is E. parva [2].
Emmonsia crescens (an agent of adiaspiromycosis), 
Blastomyces dermatitidis (the agent of blastomycosis), 
and Histoplasma capsulatum (the agent of histoplasmo-
sis) are known to form meiotic (sexual) stages, or teleo-
morphs, associated with the ascomycete genus Ajellomyces 
(Onygenaceae, Onygenales). However, no sexual stage is 
known for Emmonsia parva [3,4]. A recent phylogenetic 
study indicated that the genus Emmonsia forms part of a 
clade together with the genera Ajellomyces, Blastomyces, 
Histoplasma, and Paracoccidioides [2]. While E. crescens 
isolates are placed into two phylogenetic groups that correlate 
with their continents of origin (Eurasia and North America), 
E. parva isolates are more diverse: B. dermatitidis strains 
form a sister species of E. parva and Histoplasma capsula-
tum is also a close relative. Paracoccidioides brasiliensis and 
Histoplasma capsulatum are ancestral to most Emmonsia 
isolates [4].
Emmonsia grows moderately. Colonies are glabrous to 
velvety in texture, and are white, with buff to pale brown cen-
ters from the front, and cream to pale brown on the reverse. 
Hyphae are hyaline and septate; conidiophores are simple 
or occasionally branched at 90°C; unicellular, thin-walled, 
sub-spherical aleurioconidia (2–5 μm × 2–4 μm) are sessile 
or located on slender stalks, occurring in a solitary manner 
or in two- to three-celled chains. On blood or brain–heart 
infusion agar at 37°C–40°C and in vivo, thick-walled, large, 
liberated conidia are produced. These are adiaspores, which 
are clamydospore-like and nonreproducing.
E. crescens adiaspores are multinucleate (up to a few hun-
dred nuclei), reaching diameter of 70 μm in vitro at 37°C and 
700 μm in vivo; Emmonsia parva adiaspores are uninucleate, 
reaching diameters of 10–25 μm in vitro at 40°C and 40 μm 
in vivo. By contrast, Emmonsia pasteuriana does not pro-
duce adiaspores, but forms budding cell-like structures on 
brain–heart infusion agar at 37°C.
In infected lung tissues, inhaled conidia (2–4 μm) enlarge 
in the alveoli to become adiaconidia (up to 700 μm in diam-
eter), which are surrounded by small granulomes, with con-
centric layers of fibrous tissue in later stages of the infection. 
Adiaspores do not replicate, and become calcified at the 
primary implantation site, leading to a minimal localized 
reaction in the host tissue. However, the regular pulmonary 
functions may be hampered by the presence of adiaspores.
Emmonsia is a cosmopolitan filamentous fungus that is 
present in soil and small mammals such as rodents that act as 
the reservoir host of the fungus. Emmonsia spp. are endemic 
in southwestern United States, Australia, and eastern Europe, 
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and are responsible for a pulmonary infection known as adi-
aspiromycosis in rodents, other small mammals, and occa-
sionally in humans [6–9]. Human aspiromycosis typically 
occurs after inhalation of conidia of Emmonsia. While 
Emmonsia crescens is isolated primarily from humans, 
Emmonsia parva is often isolated from animals. Emmonsia 
pasteuriana was reported in an HIV-infected patient with a 
cutaneous disseminated infection.
29.1.2  CliniCal features and epideMiology
Adiaspiromycosis is a lung disease of humans and small 
animals resulting from the inhalation of Emmonsia conidia, 
which elicit robust, multicellular immunologic response in 
tissue against the growing conidia, leading to noncaseating 
granulomas and disturbance of normal lung function. The 
first case of human adiaspiromycosis due to Emmonsia was 
described in France in 1964. Subsequently, cases of human 
pulmonary adiaspiromycosis have been reported in Russia, 
the Czech Republic, Brazil, Honduras, Guatemala, and the 
United States, with disseminated infection occurring in 
immunocompromised persons [10–21].
The establishment of adiaspiromycosis appears to be 
dose dependent, as a small inoculum often produces no or 
mild clinical symptoms and scattered radiological pathology, 
while a heavy or repeated inoculum may develop an acute, 
sometimes severe, pulmonary disease (often referred to as 
primary progressive pulmonary adiaspiromycosis, dissemi-
nated pulmonary adiaspiromycosis, or acute pulmonary adi-
aspiromycosis), with diffuse granulomatous lesions in both 
lungs. Cleaning or playing in closed environments inhabited 
only by bats and mice, where conidia of Emmonsia sp. are 
present in soil and dust, represents a risk factor for human 
adiaspiromycosis [22].
Although most human infections are attributable to 
E. crescens, a disseminated disease caused by E. parva in 
an AIDS patient has been described (Echaverria et al. 1993). 
E. crescens tends to form larger adiaspores and has a broader 
host range and geographic distribution than E. parva.
de Almeida Barbosa et al. [22] documented three 
Brazilian cases of acute pulmonary adiaspiromycosis due 
to Emmonsia crescens. The first case involved a 52-year-old 
man, who presented with cough, mucoid expectoration, fever, 
and weight loss over the previous 5 months. Chest roentgeno-
gram showed diffuse micronodular infiltrates. Hematoxylin 
and eosin (H&E) staining of the transbronchial biopsy sec-
tions revealed helminth-like structures. Sections of lung 
biopsy revealed granulomas and characteristic adiaconidia 
as stained with fungal stains (periodic acid-Schiff [PAS] and 
Gomori-Grocott methamine-silver). The patient improved 
symptomatically without treatment. The second case con-
cerned a 47-year-old man with nonproductive cough, dys-
pnea, fever, and weight loss. A chest roentgenogram revealed 
diffuse interstitial infiltrates in both lungs. H&E-stained 
sections of a transbronchial biopsy showed two granulomas, 
one of which contained an adiaconidium; sections stained by 
Gomori methenamine silver demonstrated a fungal structure 
of 100 μm in diameter. The patient recovered without treat-
ment. The third case involved a 43-year-old man with a 
1-month history of fever (39.5°C), cough with scant expecto-
ration, weight loss (3 kg), dyspnea, and thoracic pain. A chest 
roentgenogram revealed bilateral micronodular infiltrates. 
H&E-stained sections of transbronchial biopsy demonstrated 
granulomas with characteristic adiaconidia. The patient had 
disrupted two mice nests, in a farm, 14 days before becoming 
ill. Treatment with itraconazole (200 mg/day) and prednisone 
(30 mg/day) alleviated patient’s symptoms in a week, possi-
bly reflecting the fact that enlargement of Emmonsia conidia 
causes a localized inflammatory response and Emmonsia 
conidia do not replicate and disseminate.
Nuorva et al. [23] described a case of disseminated bilat-
eral pulmonary adiaspiromycosis in a 2-year-old Finnish girl. 
Electron microscopy showed that the three layers of the spore 
wall were not typical; rather, there seemed to be a gradual 
transition between the main wall zones, possibly split into 
thin layers. Varying numbers and thicknesses were seen 
with different staining methods and in different spores. This 
patient had become infected as a result of contact with soil 
dust containing the spores in the yard surrounding her home, 
and as a result of her mother’s work in a large garden shop. 
She recovered from this rare infection after treatment with 
amphotericin B.
Dot et al. [24] presented a case of pulmonary adiaspi-
romycosis in a 30-year-old man with a 2-week history of 
unproductive cough, fever at 39°C, progressive dyspnea, tho-
racic pain, generalized weakness, and weight loss of 10 kg 
in 1 month. The patient became sick a few weeks after hav-
ing played in the surroundings of an animal burrow, which 
may have functioned as a reservoir for Emmonsia. The chest 
radiography showed diffuse bilateral interstitial pneumonia 
with a micronodular pattern, and computerized tomography 
of the chest demonstrated disseminated pulmonary nodules. 
Formalin-fixed, paraffin-embedded transbronchial biopsy 
sections (4 μm) stained with PAS revealed round or ovoid, 
occasionally elliptical adiaspores (50–100 μm) with a thick 
wall in the center of some granulomas. Culture of the bron-
choalveolar fluid (BAL) and transbronchial biopsy samples 
remained negative after 4 weeks. Sequencing analysis of 
PCR amplicon from BAL specimen using panfungal prim-
ers indicated Emmonsia crescens as the culprit. Treatment 
with oral itraconazole (200 mg/day) for 40 days improved his 
respiratory status and stabilized the pulmonary lesions.
Besides pulmonary adiaspiromycosis, Mendes et al. 
[25] described an outbreak of conjunctivitis involving 99 
case-children in Brazil, with symptoms ranging from pho-
tophobia (57%), ocular pain (42%), to blurred vision (40%). 
Unlike conjunctivitis caused by bacterial or viral pathogens, 
neither purulent conjunctival discharge nor hemorrhage was 
observed, and family members of case-patient households 
were not commonly affected. Furthermore, the disease was 
characterized by unusual, single or multiple, white, opaque 
scleral nodules, often with hyperemia or local edema, and 
in some cases with opacification extending to the lim-
bus, or angular corneal opacities and anterior uveitis with 
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granulomas in the anterior chamber. Microscopy of scleral 
biopsy samples identified spherical shapes, thick walls, and 
vacuous central area with lack of organized, internal struc-
tures consistent with adiaconidia of Emmonsia sp. (in con-
trast to Coccidiodes immitis spores that contain internal 
microsporules). Conjunctival irritation was likely due to 
exposure to Emmonsia conidia in dust caused in part by dry 
environmental conditions. Symptomatic children responded 
to corticosteroid treatment.
29.1.3  diagnosis
The diagnosis of acute pulmonary adiaspiromycosis is based 
on the following criteria: (1) an acute onset of respiratory 
and systemic symptoms, (2) a radiological picture of diffuse 
micronodular lesions in both lungs, and (3) histopathological 
demonstration of the adiaconidia in the granulomas [26]. In 
particular, microscopic observation of large, round or oval, 
thick-walled adiaspores in histopathological sections of tissue 
using PAS or other stains provides a key diagnostic feature 
for adiaspiromycosis. Adiaspores are thick walled, enlarged 
conidia that may be uninucleate (E. parva) or multinucleate 
(E. crescens). Culture of Emmonisia spp. from sputum or 
BAL is not possible because adiaconidia do not multiply and 
remain trapped within lung granulomas.
Emmonisia spp. are differentiated from Blastomyces der-
matitidis, Histoplasma capsulatum, and Paracoccidioides 
brasiliensis by their inability to convert to a yeast phase 
at 37°C. They are differentiated from Sporotrichum by 
their inability to produce large chlamydospores at 25°C. 
Emmonisia spores in tissue (i.e., adiaspores or adiaconidia) 
resemble the parasitic spherules of Coccidioides immitis but 
differ by lacking internal spores.
The variable domain D2 located in the 5′ end of large 
subunit (LSU) nuclear rRNA contains sufficient nucleotide 
differences for discrimination between Emmonisia and its 
sibling Blastomyces species [27]. The other region of diag-
nostic interest is the internal transcribed spacer (ITS) region 
of rRNA (covering the ITS1, ITS2, and 5.8S rRNA), which 
offers a suitable target for examining Emmonsia species vari-
ability and for assessing evolutionary relationships among 
several related taxa.
29.2  Methods
29.2.1  saMple preparation
Biopsy specimens are stained with PAS stain and examined 
microscopically for adiaconidia-containing granulomas. 
Portions of the samples are cultured on Sabouraud agar with 
cycloheximide (0.5 mg/mL) at 30°C [24].
Emmonsia isolates are revived from either freeze dried 
or frozen (vapor phase of liquid nitrogen) stock and grown 
at 25°C on petri plates containing pablum cereal agar for 
14–21 days. Blocks (1 cm × 1 cm) of mycelium and agar from 
cultures of Emmonsia species are excised from the culture 
plates and transferred to sterile snap-cap polypropylene tubes 
(12 mm × 75 mm; Fisher Scientific). The mycelial blocks are 
freeze dried using an Edwards Moduylo freeze-dryer [4].
Freeze-dried blocks of agar and Emmonsia mycelium 
(100 mg) are placed in 1.5 mL tubes and ground to a fine 
powder by using a 200-μL capacity pipettor tip. The fungal 
material is rehydrated with 500 μL of DNA extraction buf-
fer (50 mM Tris, 10 mM EDTA, 1% sarcosyl, pH 8.0) with 
gentle agitation for 10 min. An equal volume of 1:1 chloro-
form–phenol is added to each tube, and mixed by shaking 
for 20 min. Then, the aqueous and organic phases are sepa-
rated in a microcentrifuge for 5 min at 14,000 × g. The aque-
ous phase is pipetted into a clean tube, and 0.1 volume of 
3 M sodium acetate pH 6.0 and 1.3 volumes of ethanol are 
added. The tube is sealed, and the contents are mixed by 
inverting the tube several times. Precipitated nucleic acids 
are pelleted by centrifugation at 14,000 × g for 1 min. Ethanol 
is decanted, and the pellet is dried by inverting the tube over 
an absorbent paper for 5 min. Nucleic acids are dissolved in 
100 μL of TE buffer (10 mM Tris, 1 mM EDTA, pH 8.0), and 
250 μL of a saturated NaI solution and 10 μL of glass milk 
(GENECLEAN kit, Bio 101) are added to the tube. The tube 
is inverted periodically, and DNA is adsorbed onto the glass 
milk for 20 min. The glass milk is pelleted and rinsed, and the 
genomic DNA is eluted into 50 μL of 1/10-strength TE. DNA 
is stored at −20°C until used [4]. Alternatively, Emmonsia 
genomic DNA can be prepared by using Whatman FTA filter 
papers [28].
29.2.2  deteCtion proCedures
29.2.2.1  sequencing Analysis of Its regions
Peterson and Sigler [4] used primers ITS1 
(5′-TCCGTAGGTGAACCTGCGG-3′) and D2R to amplify 
a 1200-nucleotide fragment including ITS1, ITS2, 5.8S 
rRNA, and part of the 28S rRNA for sequencing analysis of 
Emmonsia and related organisms.
Procedure
 1. PCR mixture (100 μL) is composed of 1 μL of 
genomic DNA, 10 μL of 10× buffer, 1 μL of 50 μM 
primer ITS1, 1 μL of 50 μM primer D2R, 0.5 μL 
(2.5 U) of Taq polymerase, 10 μL of dNTP (1 mM 
concentration), and 76.5 μL of sterile deionized 
water.
 2. Amplification is conducted with 30 cycles of 96°C 
for 30 s, 53°C for 30 s, and 72°C for 2.5 min fol-
lowed by 10 min at 72°C. The amplified fragment is 
purified by using GENECLEAN kit (Bio 101) and 
eluted into 1/10-strength TE. The purified fragment 
is stored at −20°C until used in sequencing.
 3. Sequencing is performed by using primers ITS1, 
ITS2 (5′-GCTGCGTTCTTCATCGATGC-3′), ITS3 
(5′-GCATCGATGAAGAACGCAGC-3′), ITS4 
(5′-TCCTCCGCTTATTGATATGC-3′), D1, D1R, 
D2, and D2R and Applied Biosystems DyeDeoxy 
sequencing kits. The sequencing reaction mixture is 
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prepared with 1.5 pmol of primer, 200–400 ng of the 
purified DNA fragment, and sequencing reagents. 
DNA sequences are analyzed on an ABI 373-auto-
mated DNA sequencer.
 4. Alignment of overlapping and reverse complement 
strands to form a consensus sequence for each iso-
late is accomplished with an ASCII text editor. 
Alignment of sequences from different isolates is 
performed visually also by using an ASCII text edi-
tor. Phylogenetic relationships of isolates are deter-
mined by using PAUP 3.1.1. or by using programs 
from the PHYLIP package.
29.2.2.2  Panfungal Pcr and sequencing Analysis
Dot et al. [24] used panfungal primers His3 and His4 
for PCR amplification and sequencing identifica-
tion of Emmonsia and related genera. The primer His3 
(5′-GTCGTAACAAGGTTTCCGTAG-3′) is located 
at the end of 18S rRNA at positions 9–29, and His4 
(5′-AGCGGGTATCCCTACCTGAT-3′) is located at the 
beginning of 28S at positions 601–620 according in the 
sequence of Histoplasma capsulatum U18363.
Procedure
Genomic DNA is extracted from the BAL by using 
the High Pure PCR Template Preparation Kit (Roche 
Diagnostics).
 1. PCR mixture (50 μL) is composed of 2 U of FastStart 
Taq DNA polymerase (Roche Diagnostics), 5 μL of 
10× PCR buffer-MgCl2 (20 mM), 20 pmol of each 
primer, 200 μM of dATP, dGTP, dTTP, and dCTP, 
and 5 μL of DNA.
 2. Amplification is conducted in an iCycler IQ Thermal 
Cycler (Bio-Rad) with initial denaturation at 94°C 
for 3 min; 30 cycles at 94°C for 1 min, 58°C for 40 s, 
and 72°C for 1 min; and final extension at 72°C for 
5 min.
 3. PCR product (5 μL) is electrophoresed in a 2% aga-
rose gel in the presence of ethidium bromide and 
visualized under UV light. The expected PCR prod-
uct size is 613 bp. If the band is faint, reamplifica-
tion of the product may be performed by using the 
same primers.
 4. After purification, the PCR product is sequenced 
with the same PCR primers using the BigDye 
Terminator v1.1 Cycle Sequencing Kit (Applied 
Biosystems). Sequencing products are analyzed on 
an automated sequencer ABI Prism 3100 genetic 
analyzer. The BLAST analysis is used to compare 
the sequence with those at GenBank database.
29.2.2.3  sequencing Analysis of Lsu rrnA Gene
Untereiner et al. [2] utilized primers WNS9 and LR5 
(5′-ATCCTGAGGGAAACTTC-3′) to amplify a DNA fragment 
that extends from the 3′ end of the nuclear small subunit rRNA 
gene to approximately 1000 bp positions downstream from the 
5′ end of the nuclear LSU rRNA gene. The amplicon is purified 
using a QIAquick PCR Purification Kit (Qiagen). Sequencing 
reactions are performed using a Prism Dye Terminator Cycle 
Sequencing Ready Reaction Kit (Applied Biosystems) and 
primers 5.8SR, LR1, WITS3, and WNS9. Excess dye termi-
nators are removed by centrifugation using Centrisep columns 
(Princeton Separations) before analysis employing an Applied 
Biosystems 373A or 377 DNA sequencer.
Sequences are edited and assembled into larger consen-
sus sequences using Sequencher 3.0 software (Gene Codes 
Corp.). Multiple alignments are produced using Clustal X 
version 1.7. The final multiple alignments are adjusted manu-
ally after visual inspection and areas of sequence ambigu-
ity are eliminated. Phylogenetic relationships are inferred 
from aligned sequences using the maximum parsimony (MP) 
method found in PAUP (beta version 4.0b10). Gaps are treated 
as missing in all analyses. Heuristic searches are performed 
employing tree bisection–reconstruction (TBR) branch swap-
ping with the MulTrees and steepest descent options acti-
vated, or using 1000 random addition sequence replicates.
29.3  concLusIon
Members of the genus Emmonsia are saprophytic fungi 
that are commonly present in soil and small mammals (e.g., 
rodents, otters, ground squirrels, goats, dogs, hedgehogs, 
raccoons, horses, and beavers). The teleomorphs of the 
genus Emmonsia along with the genera Blastomyces and 
Histoplasma are found in the genus Ajellomyces.
Among the species in the genus Emmonsia, E. crescens 
and E. parva spores are capable of entering the alveoli of 
mammalian hosts through inhalation, which expand to 
become adiaspores (adiacanidia), and cause a granulomatous 
inflammatory reaction, leading to a pulmonary disease known 
as adiaspiromycosis in animals and occasionally in humans. 
Most human adiaspiromycosis cases are due to E. crescens. 
Although human adiaspiromycosis often regresses spontane-
ously, sometimes the disease may persist, resulting in pneu-
monia or fatal respiratory failure [29,30].
Because Emmonsia spp. are not easily cultured, diagnosis 
of adiaspiromycosis has relied on histological examination 
of biopsies for large, round or oval, thick-walled adiaspores 
using PAS or other stains. Use of molecular techniques, espe-
cially sequencing analysis of the D2 region of the LSU rRNA 
gene and the ITS regions of rRNA biology, provides a valu-
able approach for improving the detection and diagnosis of 
human adiaspiromycosis.
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